S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function.
Xiong W, Chen S, Xiang H, Zhao S, Xiao J, Li J, Liu Y, Shu Z, Ouyang J, Zhang J, Liu H, Wang X, Zou H, Chen Y, Chen A, Lu H.
Xiong W, et al. Among authors: chen a, chen s, chen y.
Pulm Pharmacol Ther. 2023 Aug;81:102228. doi: 10.1016/j.pupt.2023.102228. Epub 2023 Jun 8.
Pulm Pharmacol Ther. 2023.
PMID: 37295666